ロード中...
Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
BACKGROUND. Thrombotic events, arterial or venous in origin, still remain a source of substantial morbidity and mortality in cancer patients. The propensity for their development in oncology patients is partially a consequence of the disease itself and partially a result of our attempts to treat it....
保存先:
| 出版年: | Radiol Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Versita, Warsaw
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387995/ https://ncbi.nlm.nih.gov/pubmed/26029030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2014-0024 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|